CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
We have now added a new section called the "Assay History List" to the "At A Gla...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...